Two different single-dose allergen-blocking antibodies, one for cat allergy and one for birch allergy, significantly reduced allergic ocular symptoms, according to findings from two phase 3 trials.
Historical Data is currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback